The massive drug company Pfizer Inc. is facing very serious allegations about Zantac, one of the most popular heartburn medications in the United States. Lawsuits allege that the drug itself can cause cancer. This is massive news with millions of people using it every year. The potential exposure is unprecedented.
It goes beyond the mere risk to consumers, though. The lawsuit also alleges that Pfizer knew about the risk and covered it up so that people would keep buying the product. Allegations include:
- Unjust enrichment
- Breaches of warranty
- Fraudulent concealment
- Breaking the New Jersey Consumer Fraud Act
These are not the type of accusations to come down lightly, and the company’s financial future could hang in the balance.
What is Zantac?
Zantac is a medication that people can take when experiencing heartburn. It’s an over-the-counter medication that typically comes in a small plastic bottle. Simple instructions indicate that taking the pills can reduce symptoms of heartburn for most adults.
That said, asking what Zantac really is has become a bit bigger of a question in recent months. The lawsuit says that the drug contains N-nitrosodimethylamine, which is often called NDMA. This is a carcinogen for humans, meaning it can lead to cancer. Not only does the lawsuit claim that the drug contains this ingredient, but it says that Pfizer failed to list it on the label.
It is essential for companies to offer full disclosure regarding any and all ingredients in their products. This allows consumers to make an informed, educated decision about anything they put into their bodies. Failing to list ingredients violates their rights because they think those ingredients do not exist and take them unwittingly.
When looking at something as dangerous as a human carcinogen, it’s clear why rules like this exist. Most consumers would not willingly subject themselves to that level of risk merely to cure heartburn. The fact that the company covered it up could indicate that they understood the potential financial implications and did not want people to stop buying.
Backing up this lawsuit is a nation-wide recall that has been going on since September of 2019. Ranitidine products, including Zantac, have gotten pulled from shelves. The FDA spurred this when they uncovered the high NDMA levels. It’s not just Zantac, either, but all generic versions that contain the same ingredients.
With a case like this, very lives could be on the line. Cancer is a serious and often fatal disease, even with the advances in modern medicine. If you used Zantac, make sure you know exactly what options you have.